April 18, 2006

Back
... Up One Level
Next

April 18, 2006

April 18 – April 24

April 18th: U.S. FDA Approves GE Healthcare's Next-Generation Digital Mammography System for Improved Breast Care

GE Healthcare, a unit of General Electric Company (NYSE:GE ), today announced that it has received U.S. Food and Drug Administration (FDA) approval for its new mammography platform that will improve the standard of care for millions of women around the world. The Senographe® Essential is the next-generation of GE's proven Senographe Full Field Digital Mammography systems.

The new Senographe Essential will enhance the way clinicians can evaluate women for breast cancer, by enhancing image quality. With a 24 x 31 cm detector size, the Senographe Essential offers the largest active field of view in the industry. The foundation of the Senographe Essential imaging excellence is GE's advanced digital detector, which at low doses delivers the industry's highest Detective Quantum Efficiency (DQE) - the new standard for quantifying digital X-ray image quality.

In 2000, GE was the first company to introduce full-field digital mammography for patient use, and today there are more than 1,500 GE Senographe systems in use worldwide. More than 25 million women have been examined using GE Senographe FFDM systems. GE Healthcare spent 15 years and more than $200 million developing the Senographe systems' Revolution digital flat panel technology. As a result, GE holds more than 160 U.S. patents for its exclusive digital flat panel X-ray technology.

April 20th: Boston Scientific Completes Combination with Guidant

Boston Scientific Corporation today announced that it has completed its combination with Guidant Corporation, creating a global leader in cardiovascular devices and one of the largest medical technology companies in the world.

"This is a momentous day for the employees and stockholders of the new Boston Scientific, as well as for thousands of physicians and millions of patients around the world," said Pete Nicholas, Chairman of Boston Scientific. "As we begin this new chapter in Boston Scientific's history, we are committed to building on our long, mutual tradition of technological innovation that helps physicians provide life-saving treatments to their patients. We are also committed to maintaining a culture that values initiative, creativity and collaboration -- and that recognizes the talents and contributions of people who make a difference for our company and our customers."

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

April 24th: Atrium Medical Corporation Receives FDA Approval for a New Vascular Implant Technology - FLIXENE(TM)

Atrium Medical Corporation announced today that it has received US FDA 510(k) marketing clearance for a new vascular product called FLIXENE. Indicated for vascular access and arterial vascular reconstruction, FLIXENE vascular grafts offer the discriminating surgeon an exciting new alternative to traditional 20 to 30 year old vascular graft technologies.

Atrium's FLIXENE vascular graft is a "next generation" composite graft construction that offers exceptional strength, handling and durability. Built from a proprietary biomaterial film lamination process, FLIXENE exhibits unequalled kink and compression resistance for improved surgical handling and minimal needle hole bleeding. This extraordinary biomaterial provides unsurpassed "burst" and "suture strength" and is designed to minimize "weeping" often seen with traditional vascular bypass grafts following implantation.

FLIXENE is the latest advance in a series of unique medical device innovations, built upon a strong 25 year heritage of excellence in advanced polymer and biomaterial science. This late breaking technology introduction also creates a brand new implant platform for future drug eluting and coating developments, to further advance implant performance and patient outcomes in a wide variety of challenging vascular disease conditions which require surgical intervention.
Atrium Medical Corporation of Hudson, New Hampshire, celebrating 25 years of US based healthcare innovation manufactures over two million sterile medical devices each year which are distributed worldwide.

If you have any comments regarding this update, please email: info@mdiconsultants.com

Internet Presence, Creation, Design & Maintenance by: Windco.com, Inc